Acxiom Corporation (NASDAQ:ACXM): Can It Deliver A Superior ROE To The Industry?

In this article:

Acxiom Corporation (NASDAQ:ACXM) generated a below-average return on equity of 1.32% in the past 12 months, while its industry returned 13.03%. Though ACXM’s recent performance is underwhelming, it is useful to understand what ROE is made up of and how it should be interpreted. Knowing these components can change your views on ACXM’s below-average returns. Metrics such as financial leverage can impact the level of ROE which in turn can affect the sustainability of ACXM’s returns. Let me show you what I mean by this. Check out our latest analysis for Acxiom

What you must know about ROE

Return on Equity (ROE) is a measure of Acxiom’s profit relative to its shareholders’ equity. For example, if the company invests $1 in the form of equity, it will generate $0.01 in earnings from this. While a higher ROE is preferred in most cases, there are several other factors we should consider before drawing any conclusions.

Return on Equity = Net Profit ÷ Shareholders Equity

Returns are usually compared to costs to measure the efficiency of capital. Acxiom’s cost of equity is 9.88%. Given a discrepancy of -8.56% between return and cost, this indicated that Acxiom may be paying more for its capital than what it’s generating in return. ROE can be dissected into three distinct ratios: net profit margin, asset turnover, and financial leverage. This is called the Dupont Formula:

Dupont Formula

ROE = profit margin × asset turnover × financial leverage

ROE = (annual net profit ÷ sales) × (sales ÷ assets) × (assets ÷ shareholders’ equity)

ROE = annual net profit ÷ shareholders’ equity

NasdaqGS:ACXM Last Perf Mar 29th 18
NasdaqGS:ACXM Last Perf Mar 29th 18

The first component is profit margin, which measures how much of sales is retained after the company pays for all its expenses. Asset turnover reveals how much revenue can be generated from Acxiom’s asset base. And finally, financial leverage is simply how much of assets are funded by equity, which exhibits how sustainable the company’s capital structure is. Since ROE can be artificially increased through excessive borrowing, we should check Acxiom’s historic debt-to-equity ratio. Currently the debt-to-equity ratio stands at a low 29.68%, which means Acxiom still has headroom to take on more leverage in order to increase profits.

NasdaqGS:ACXM Historical Debt Mar 29th 18
NasdaqGS:ACXM Historical Debt Mar 29th 18

Next Steps:

ROE is one of many ratios which meaningfully dissects financial statements, which illustrates the quality of a company. Acxiom’s below-industry ROE is disappointing, furthermore, its returns were not even high enough to cover its own cost of equity. However, ROE is not likely to be inflated by excessive debt funding, giving shareholders more conviction in the sustainability of returns, which has headroom to increase further. Although ROE can be a useful metric, it is only a small part of diligent research.

For Acxiom, there are three important factors you should look at:

  1. Financial Health: Does it have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.

  2. Valuation: What is Acxiom worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether Acxiom is currently mispriced by the market.

  3. Other High-Growth Alternatives : Are there other high-growth stocks you could be holding instead of Acxiom? Explore our interactive list of stocks with large growth potential to get an idea of what else is out there you may be missing!


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.

Advertisement